What Scripta Therapeutics say about themselves
“Biology decoded, disease undone - modulating transcription factors to restore health”
Scripta Therapeutics Limited
- Incorporated
- 4 October 2024 (2 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Ray BarlowMarianne Mertens
- Accounts type
- Small
- Region
- South East
- Address
- Magdalen CentreRobert Robinson AvenueOxfordOX4 4GA
Website & contact details
- Website
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 17 October 2027
- Last conf. stmt
- 3 October 2026
Officers 4 active
Officer details are public data from the Companies House register.
Barlow, Ray
Director · Appointed 25 September 2025
British
Born May 1968 (58)
Mertens, Marianne, Dr
Director · Appointed 25 September 2025
German
Born March 1984 (42)
Director · Appointed 17 March 2025
Also at Acionna Therapeutics Ltd · more companies
British
Born May 1971 (55)
Hamley, Peter Richard John, Dr
Director · Appointed 4 October 2024
British
Born June 1966 (60)
Officer history (1 former)
25 September 2025
Appointed Barlow, Ray as Director
25 September 2025
Appointed Mertens, Marianne, Dr as Director
25 September 2025
Resigned Adams, Jan, Dr as Director
17 March 2025
17 March 2025
Appointed Adams, Jan, Dr as Director
4 October 2024
Appointed Hamley, Peter Richard John, Dr as Director
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (1)
17 March 2025
Ceased Peter Richard John Hamley — Owns 75–100% of shares
Financials
Balance sheet as at 31 December 2025 · small accounts
- Net Assets
- £2,864,971
- Cash
- £2,424,318
- Profit
- (£1,785,543)
- Employees
- 5
- Debt Ratio
- 19%
- Current Ratio
- 4.4x
- Return on Equity
- -62%
Balance sheet detail
| 2025 | |
|---|---|
| Fixed Assets | £603,144 |
| Current Assets | £2,919,332 |
| Cash | £2,424,318 |
| Creditors (< 1 year) | £657,505 |
| Net Current Assets | £2,261,827 |
| Net Assets | £2,864,971 |
| Shareholder Funds | £2,864,971 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 8 September 2026 | Statement of capital following an allotment of shares |
Some other companies at this address
Other companies in this industry
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →